InflaRx Regains Nasdaq Compliance, Resolving Minimum Bid Price Issue
IFRX has more than doubled off its 52-week low of $0.711 on elevated volume (6.2× avg).
Summary
InflaRx N.V. announced it has regained compliance with Nasdaq's minimum bid price requirement, removing the risk of delisting.
Key Events · Corporate Governance and Compliance · IFRX
-
Regains Nasdaq Compliance
InflaRx N.V. received confirmation from Nasdaq that it has regained compliance with the minimum bid price requirement (Rule 5450(a)(1)).
-
Resolution of Prior Non-Compliance
The company was previously notified on March 11, 2026, of non-compliance with the $1.00 minimum bid price rule.
-
Shares Above $1.00 for 10 Days
Compliance was achieved as the closing bid price of the company's ordinary shares was $1.00 or greater for 10 consecutive business days, from April 13 to April 24, 2026.
Analysis · IFRX · Life Sciences
This 6-K confirms that InflaRx N.V. has successfully met Nasdaq's minimum bid price requirement, with its shares trading above $1.00 for 10 consecutive business days. This positive development resolves the non-compliance notice received on March 11, 2026, and removes the immediate threat of delisting from the Nasdaq exchange. Regaining compliance is crucial for maintaining investor confidence and ensuring continued liquidity for the company's shares.
At the time of this filing, IFRX was trading at $1.67 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $120.7M. The 52-week trading range was $0.71 to $1.95. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.